JP7767500B2 - アトピー性皮膚炎の重症度の検出方法 - Google Patents

アトピー性皮膚炎の重症度の検出方法

Info

Publication number
JP7767500B2
JP7767500B2 JP2024075513A JP2024075513A JP7767500B2 JP 7767500 B2 JP7767500 B2 JP 7767500B2 JP 2024075513 A JP2024075513 A JP 2024075513A JP 2024075513 A JP2024075513 A JP 2024075513A JP 7767500 B2 JP7767500 B2 JP 7767500B2
Authority
JP
Japan
Prior art keywords
atopic dermatitis
severity
genes
expression
mild
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2024075513A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024161911A (ja
JP2024161911A5 (cg-RX-API-DMAC7.html
Inventor
直人 高田
哲矢 桑野
高良 井上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of JP2024161911A publication Critical patent/JP2024161911A/ja
Publication of JP2024161911A5 publication Critical patent/JP2024161911A5/ja
Priority to JP2025182297A priority Critical patent/JP2026012310A/ja
Application granted granted Critical
Publication of JP7767500B2 publication Critical patent/JP7767500B2/ja
Priority to JP2025278912A priority patent/JP2026040607A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Sustainable Development (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2024075513A 2023-05-08 2024-05-07 アトピー性皮膚炎の重症度の検出方法 Active JP7767500B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2025182297A JP2026012310A (ja) 2023-05-08 2025-10-29 アトピー性皮膚炎の重症度の検出方法
JP2025278912A JP2026040607A (ja) 2023-05-08 2025-12-23 アトピー性皮膚炎の重症度の検出方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023076892 2023-05-08
JP2023076892 2023-05-08

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025182297A Division JP2026012310A (ja) 2023-05-08 2025-10-29 アトピー性皮膚炎の重症度の検出方法

Publications (3)

Publication Number Publication Date
JP2024161911A JP2024161911A (ja) 2024-11-20
JP2024161911A5 JP2024161911A5 (cg-RX-API-DMAC7.html) 2025-02-18
JP7767500B2 true JP7767500B2 (ja) 2025-11-11

Family

ID=93430164

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2024075513A Active JP7767500B2 (ja) 2023-05-08 2024-05-07 アトピー性皮膚炎の重症度の検出方法
JP2025182297A Pending JP2026012310A (ja) 2023-05-08 2025-10-29 アトピー性皮膚炎の重症度の検出方法
JP2025278912A Pending JP2026040607A (ja) 2023-05-08 2025-12-23 アトピー性皮膚炎の重症度の検出方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2025182297A Pending JP2026012310A (ja) 2023-05-08 2025-10-29 アトピー性皮膚炎の重症度の検出方法
JP2025278912A Pending JP2026040607A (ja) 2023-05-08 2025-12-23 アトピー性皮膚炎の重症度の検出方法

Country Status (2)

Country Link
JP (3) JP7767500B2 (cg-RX-API-DMAC7.html)
WO (1) WO2024232368A1 (cg-RX-API-DMAC7.html)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021221138A1 (ja) 2020-05-01 2021-11-04 花王株式会社 アトピー性皮膚炎の検出方法
JP2022016416A (ja) 2020-07-10 2022-01-21 花王株式会社 アトピー性皮膚炎の重症度の検出方法
JP2022049694A (ja) 2020-09-16 2022-03-29 花王株式会社 乳幼児アトピー性皮膚炎の検出方法
JP2022087074A (ja) 2020-11-30 2022-06-09 花王株式会社 アトピー性皮膚炎の症度の検出方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021221138A1 (ja) 2020-05-01 2021-11-04 花王株式会社 アトピー性皮膚炎の検出方法
JP2022016416A (ja) 2020-07-10 2022-01-21 花王株式会社 アトピー性皮膚炎の重症度の検出方法
JP2022049694A (ja) 2020-09-16 2022-03-29 花王株式会社 乳幼児アトピー性皮膚炎の検出方法
JP2022087074A (ja) 2020-11-30 2022-06-09 花王株式会社 アトピー性皮膚炎の症度の検出方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GUTTMAN-YASSKY, E. et al.,Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis,JAMA Dermatology,2019年,Vol.155, No.12,P.1358-1370,doi:10.1001/jamadermatol.2019.2983

Also Published As

Publication number Publication date
JP2024161911A (ja) 2024-11-20
WO2024232368A1 (ja) 2024-11-14
JP2026012310A (ja) 2026-01-23
JP2026040607A (ja) 2026-03-09

Similar Documents

Publication Publication Date Title
JP7849812B2 (ja) パーキンソン病の検出方法
WO2021221138A1 (ja) アトピー性皮膚炎の検出方法
JP7743217B2 (ja) アトピー性皮膚炎の重症度の検出方法
JP7743239B2 (ja) 乳幼児アトピー性皮膚炎の検出方法
JP7762549B2 (ja) アトピー性皮膚炎の症度変化の検出方法
JP7743475B2 (ja) アトピー性皮膚炎の検出方法
JP7743289B2 (ja) アトピー性皮膚炎の症度の検出方法
JP7743474B2 (ja) 乳幼児アトピー性皮膚炎の検出方法
WO2022220298A1 (ja) 乳幼児おむつ皮膚炎の症度の検出方法
JP2026012310A (ja) アトピー性皮膚炎の重症度の検出方法
JP7847451B2 (ja) アトピー性皮膚炎による皮膚痒みの症度悪化の検出方法
JP7847450B2 (ja) アトピー性皮膚炎の症度悪化の検出方法
JP2023002298A (ja) 糖尿病指標値の検出方法
JP7750481B2 (ja) 内臓脂肪面積の検出方法
JP2023073134A (ja) ホットフラッシュの検出方法
JP2023073135A (ja) 更年期障害の重症度の検出方法
WO2022220299A1 (ja) 乳幼児顔湿疹の症度の検出方法
JP2023048811A (ja) 疲労の検出方法
JP2023045067A (ja) 不眠の検出方法
JP2023048810A (ja) 慢性ストレスレベルの検出方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240515

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250311

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250428

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250709

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250930

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20251029

R150 Certificate of patent or registration of utility model

Ref document number: 7767500

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150